Advertisement

Table of Contents

July 25, 2019; 134 (4)

BLOOD COMMENTARIES

HOW I TREAT

CLINICAL TRIALS AND OBSERVATIONS

  • Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy
    Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy
    Emanuele Zucca, Stephanie Rondeau, Anna Vanazzi, Bjørn Østenstad, Ulrich J. M. Mey, Daniel Rauch, Björn E. Wahlin, Felicitas Hitz, Micaela Hernberg, Ann-Sofie Johansson, Peter de Nully Brown, Hans Hagberg, Andrés J. M. Ferreri, Andreas Lohri, Urban Novak, Thilo Zander, Hanne Bersvendsen, Mario Bargetzi, Walter Mingrone, Fatime Krasniqi, Stefan Dirnhofer, Stefanie Hayoz, Hanne Hawle, Simona Berardi Vilei, Michele Ghielmini and Eva Kimby for the Swiss Group for Clinical Cancer Research and the Nordic Lymphoma Group

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

LETTER TO BLOOD

BLOOD WORK